Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Amar Singh

View as an RSS Feed
View Amar Singh's Comments BY TICKER:
Latest  |  Highest rated
  • Value Investors Take Note: Fire Sale On This Heart Failure Asset [View article]
    I won't hold in for two years . oops .
    May 21 01:13 AM | 0 Likes Like |Link to Comment
  • Delcath Systems: Too Many Red Flags To Hold Through May 2nd ODAC [View article]
    Great article Sir.
    May 2 05:56 AM | 1 Like Like |Link to Comment
  • An Analysis Of MGT's Patent And Its Legal Counsel [View article]
    It rallied yesterday I $MGTsaw volume coming in and grabbed 2k at 3.22.
    Apr 9 07:11 AM | 1 Like Like |Link to Comment
  • Apple: Why I Am Strongly Bearish - Take Two [View article]
    So it was 220 when u first posted ? if someone followed your ADVICE and used margin to SHORT it, He would have 90% loss of his $$$. Woww !!
    Aug 28 11:28 AM | 2 Likes Like |Link to Comment
  • Is Arena’s Lorcaserin More Valuable Than Dendreon’s Provenge? [View article]
    SUPG 's phase 3 AML results due soon keep radar . i like BIOD for diabetes . it happens i fu r overwright and BIOD's drug had fda 10/30
    May 15 12:59 PM | 0 Likes Like |Link to Comment
  • Why Biodel Is Breathing Easy, Part 2 [View article]
    VIATAB can CRUSH all competitor and $BIOD to infinity
    May 7 12:55 PM | 0 Likes Like |Link to Comment
  • Why Biodel Is Breathing Easy, Part 2 [View article]
    lOOKS great TO ME As part of the normal course of the FDA’s review, Biodel has received and responded to the FDA’s 74-day letter regarding the NDA and recently submitted a 120-day safety update on patient experience with the drug, including data from the recently completed VIAject Phase 3 extension trials. The company will be presenting results from the VIAject program at the Deutsche Diabetes Gesellschaft meeting in Stuttgart, Germany, May 12-15, and will be presenting a number of abstracts on several of the company’s product candidates at the American Diabetes Association’s annual meeting in June. www.pharmacynews.eu/he...
    May 7 09:59 AM | 0 Likes Like |Link to Comment
  • Why Biodel Is Breathing Easy, Part 2 [View article]
    actually my blog alerted this first along with tapebeat guys,
    May 5 07:31 AM | 0 Likes Like |Link to Comment
  • Takeover Speculation Swarms at AspenBio Pharma [View article]
    nice analysis what is next pick?
    Apr 27 07:32 AM | 0 Likes Like |Link to Comment
  • Baidu: Wall Street's High Expectations Threaten Share Price [View article]
    also keep radar REDF and SIFY india picks and GIGM
    Apr 25 08:44 PM | 0 Likes Like |Link to Comment
  • Preview of AspenBio's Potentially Blockbuster Clinical Trials [View article]
    your website has no updates since January. what happened
    Apr 25 10:19 AM | 0 Likes Like |Link to Comment
  • The Carlyle Group Takes Position in China Recycling Energy Corp. [View article]
    i didn't read your article then. i wished i had. nice DD
    Mar 20 11:11 AM | 0 Likes Like |Link to Comment
  • Arrowhead Research Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript [View article]
    woww nice one
    Jan 12 12:06 AM | 0 Likes Like |Link to Comment
  • Bears Target McKesson [View article]
    what an anylysis tagthatstock
    GS needs to hire u
    Nov 18 10:28 AM | 0 Likes Like |Link to Comment
  • Why I'm Buying Citigroup Stock [View article]
    if BAC can go from 2.50 to 14 why cann't C?
    Aug 1 09:37 PM | 0 Likes Like |Link to Comment
COMMENTS STATS
44 Comments
6 Likes